New York

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Dermatomyositis and polymyositis (myositis)1 trial
• Endometrial cancer1 trial
• Lung cancer1 trial
• Lupus (SLE)1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial
• Rheumatoid arthritis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 12 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Bristol-Myers Squibb2 trials
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

• Recruiting

  A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

  NCT06997029· Phase 1· Bristol-Myers Squibb· Source

  Contact: Site 0011

• Active, not recruiting

  A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

  NCT05869955· Phase 1· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Endometrial cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting

Closed trials

• Completed

  A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)

  NCT02998528· Phase 3· Bristol-Myers Squibb· Source